Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis

Molecular Microbiology

Volumn 34, Issue 1, 1999, Pages 169-180

  Schaller, Martin ^b   Korting, Hans C ^b   Schäfer, Wilhelm ^a   Bastert, Janine ^b   Chen, WenChieh ^b   Hube, Bernhard ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; ASPARTIC PROTEINASE INHIBITOR; CANDIDA ANTIGEN; GENE PRODUCT; PEPSTATIN; POLYCLONAL ANTIBODY;

ARTICLE; CANDIDA ALBICANS; CELL WALL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FUNGUS MUTANT; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MOUTH INFECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THRUSH; TISSUE INJURY;

ANTIGENS, FUNGAL; ASPARTIC ENDOPEPTIDASES; CANDIDA ALBICANS; CANDIDIASIS, ORAL; EPITHELIUM; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MICROSCOPY, IMMUNOELECTRON; MUTATION; PEPSTATINS; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

CANDIDA ALBICANS; FUNGI;

EID: 0001421998     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.1999.01590.x     Document Type: Article

References (45)

1. Borg-von Zepelin, M., Beggah, S., Boggian, K., Sanglard, D., and Monod, M. (1998) The expression of secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol Microbiol 28: 543-554.
2. Borg-von Zepelin, M., and Rüchel, R. (1988) Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect Immun 56: 626-631.
3. Colina, A.R., Aumont, F., Deslauriers, N., Belhumeur, P., and de Repentigny, L. (1996) Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect Immun 64: 4514-4519.
4. Cutler, J.E. (1991) Putative virulence factors of Candida albicans. Annu Rev Microbiol 45: 187-218.
5. Dalton, A.J. (1955) A chrome-osmium fixative for electron microscopy. Anat Rec 121: 281.
6. De Bernardis, F., Cassone, A., Sturtevant, J., and Calderone, R. (1995) Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect Immun 63: 1887-1892.
7. De Bernardis, F., Boccanera, M., Adriani, D., Spreghini, E., Santoni, G., and Cassone, A. (1997) Protective role of anti-mannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun 65: 3399-3405.
8. De Bernardis, F., Arancia, S., Morelli, L., Hube, B., Sanglard, D., Schäfer, W., and Cassone, A. (1999) Evidence that members of secretory aspartyl proteinases gene family, in particular SAP2, are virulence factor for Candida vaginitis. J Infect Dis 179: 201-208.
9. Dubois, N., Colina, A.R., Aumont, F., Belhumeur, P., and de Repentigny, L. (1998) Overexpression of Candida albicans secretory aspartyl proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in mice. Microbiology 144: 2299-2310.
10. Fallon, K., Bausch, K., Noonan, B., Huguenel, E., and Tamburini, P. (1997) Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect Immun 65: 551-556.
11. Farrell, S.M., Hawkins, D.F., and Ryder, T.A. (1983) Scanning electron microscope study of Candida albicans invasion of cultured human cervical epithelial cells. Sabourodia 21: 251-254.
12. Fonzi, W.A., and Irwin, M.Y. (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728.
13. Ghannoum, M., and Abu Elteen, K. (1986) Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J Med Vet Mycol 24: 407-413.
14. Gillum, A.M., Tsay, E.Y.H., and Kirsch, D.R. (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.
15. Goldman, R.C., Frost, D.J., Capobianco, J.O., Kadam, S., Rasmussen, R.R., and Abad-Zapatero, C. (1995) Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis. Infect Agents Dis 4: 228-247.
16. Harder, J., Bartels, J., Christophers, E., and Schröder, J.M. (1997) A peptide antibiotic from human skin. Nature 387: 861.
17. Hoegl, L., Ollert, M., and Korting, H.C. (1996) The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J Mol Med 74: 135-142.
18. Homma, M., Chibana, H., and Tanaka, K. (1991) Induction of extracellular proteinase in Candida albicans. J Gen Microbiol 139: 1187-1193.
19. Hube, B. (1996) Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 7: 55-69.
20. Hube, B. (1998) Possible role of proteinases in Candida infections. Revista Iberoamericana Micologia 15: 68-71.
21. Hube, B., Monod, M., Schofield, D.A., Brown, A.J.P., and Gow, N.A.R. (1994) Expression of seven members of the gene family encoding secretory aspartyl proteinase in Candida albicans. Mol Microbiol 14: 87-99.
22. Hube, B., Sanglard, D., Odds, F.C., Hess, D., Monod, M., Schäfer, W., et al. (1997) Gene disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2 and SAP3 in Candida albicans attenuates virulence. Infect Immun 65: 3529-3538.
23. Ibrahim, A.S., Scott, G.F., Sanglard, D., Edwards, J.E., and Hube, B. (1998) Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect Immun 66: 3003-3005.
24. Karnovsky, M.J. (1965) A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol 27: 137-138.
25. Korting, H.C., Schaller, M., Eder, G., Hamm, G., Böhmer, U., and Hube, B. (1999) Influence of the HIV-proteinase inhibitors saquinavir and indinavir on the in vitro activity of secreted aspartyl proteinases from Candida albicans isolates of HIV-infected patients. Antimicrob Agents Chemother 43: 2038-2042.
26. Kwon-Chung, K.J., Lehman, D., Good, C., and Magee, P.T. (1985) Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun 49: 571-575.
27. MacDonald, F., and Odds, F.C. (1983) Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol 129: 431-438.
28. Magee, B.B. (1994) Formation of Candida spheroplasts. In Molecular Biology of Pathogenic Fungi. Maresca, B., and Kobayashi, G.S. (eds). New York: Telos Press, pp. 113-115.
29. Maneu, V., Cervera, A.M., Martinez, J.P., and Gozalbo, D. (1996) Molecular cloning and characterization of a Candida albicans gene (EFB1) coding for the elongation factor EF-1β. FEMS Microbiol Lett 145: 157-162.
30. Monod, M., Togni, G., Hube, B., and Sanglard, D. (1994) Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 13: 357-368.
31. Monod, M., Hube, B., Hess, D., and Sanglard, D. (1998) Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida Albicans. Microbiology 144: 2731-2737.
32. Morrow, B., Srikantha, T., and Soll, D.R. (1992) Transcription of the gene for a pepsinogen, PEP1, is regulated by white-opaque switching in Candida albicans. Mol Cell Biol 12: 2997-3005.
33. Naglik, J., Newport, G., White, T.C., Fernandes-Naglik, L.L., Greenspan, J.S., Greenspan, D., et al. (1999) In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect Immun 67: 2482-2490.
34. Odds, F.C. (1994) Candida species and virulence. Am Soc Microbiol News 60: 313-318.
35. Ollert, M.W., Söhnchen, R., Korting, H.C., Ollert, U., Bräutigam, S., and Bräutigam, W. (1993) Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect Immun 61: 4560-4568.
36. Ray, T.L., and Payne, C.D. (1988) Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect Immun 56: 1942-1949.
37. Reichart, P.A., Philipsen, H.P., Schmidt-Westhausen, A., and Samaranayake, L.P. (1995) Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings. J Oral Pathol Med 24: 276-281.
38. Rüchel, R. (1992) Proteinase. In New Strategies in Fungal Disease. Bennett, J.E., Hay, R.J., and Peterson, P.K. (eds). Edinburgh: Churchill Livingstone, pp. 17-31.
39. Rupniak, H.T., Rowlatt, C., Lane, E.B., Steele, J.G., Trejdosiewicz, L.K., Laskiewicz, B., et al. (1985) Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J Natl Cancer Inst 75: 621-635.
40. Sanglard, D., Hube, B., Monod, M., Odds, F.C., and Gow, N.A.R. (1997) A triple deletion in SAP4, SAP5 and SAP6 secretory aspartyl proteinase genes of Candida albicans causes attenuated virulence. Infect Immun 65: 3539-3546.
41. Schaller, M., Schäfer, W., Korting, H.C., and Hube, B. (1998) Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 29: 605-615.
42. Schaller, M., Hube, B., Ollert, M.W., Schäfer, W., Borgvon Zepelin, M., Thoma-Greber, E., and Korting, H.C. (1999) In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol 112: 383-386.
43. Stringaro, A., Crateri, P., Pellegrini, G., Arancia;, G., Cassone, A., and De Bernardis, F. (1997) Ultrastructural localization of the secretory aspartyl proteinase in Candida albicans cell wall in vitro and in experimentally infected rat vagina. Mycopathologia 137: 95-105.
44. Watts, H.J., Cheah, F.S., Hube, B., Sanglard, D., and Gow, N.A.R. (1998) Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol Lett 159: 129-135.
45. White, T.C., and Agabian, N. (1995) Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, levels are determined by environmental factors. J Bacteriol 177: 5215-5221.